Eisai Co Ownership

EII Stock  EUR 30.05  1.24  4.30%   
Eisai Co holds a total of 286.7 Million outstanding shares. 30% of Eisai Co outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Eisai Co in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Eisai Co, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eisai Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Eisai Stock Ownership Analysis

About 49.0% of the company shares are held by institutions such as insurance companies. The book value of Eisai Co was currently reported as 2698.92. The company last dividend was issued on the 30th of March 2023. Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan. EISAI LTD operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10683 people. To learn more about Eisai Co call Haruo Naito at 81 3 3817 3700 or check out https://www.eisai.co.jp.

Eisai Co Outstanding Bonds

Eisai Co issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eisai Co uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eisai bonds can be classified according to their maturity, which is the date when Eisai Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Eisai Stock

Eisai Co financial ratios help investors to determine whether Eisai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai Co security.